Watch DNTH. Know when insiders buy.
One email the day a filing lands. Free.
DNTH
Dianthus Therapeutics, Inc. /DE/
78.10
−0.65 −0.83%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
38
FLAG · insiders 25, shorts 50
Insiders, 90 days
−$4.5M
net selling · 0 buys, 8 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $4.4BP/E —DIV YIELD —FCF YIELD -3.56%REV TTM —NET INCOME −$192.2MNET CASH —52W 32.92 – 115.96SEC XBRL · TTM TO Invalid Date
One year, everything drawn on
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-10-21
Insiders (90d): $4.5M net selling
Shorts (latest report): 8.4M short · +12K last period
Every line of the math38FLAG
Insider activity
ALL 8| Date | Insider | Type | Value |
|---|---|---|---|
| Sep 17 | CHIEF ACCOUNTING OFFICER | Sell | $73K |
| Sep 17 | CHIEF ACCOUNTING OFFICER | Sell | $114K |
| Sep 17 | CHIEF ACCOUNTING OFFICER | Sell | $358K |
| Sep 17 | CHIEF ACCOUNTING OFFICER | Sell | $686K |
| Sep 17 | CHIEF ACCOUNTING OFFICER | Sell | $796K |
| Sep 1 | EVP, Head of R&D | Sell | $1.4M |